Ultomiris Market Trends, Growth Drivers, and Future Outlook...

blog ekledi Diğer

2026-04-30 05:19:20

Ultomiris Market Trends, Growth Drivers, and Future Outlook (2026–2033)

Ultomiris Drug (ravulizumab) Market is a long-acting monoclonal antibody developed to treat rare complement-mediated disorders. As a C5 complement inhibitor, it plays a critical role in managing diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder...

0 Yorumlar 0 Paylaşımlar 59 Görüntülenme 0 İncelemeler